Published on 20/12/2025
Building Robust Internal Review and Quality Check Processes for Regulatory Submissions
Introduction to Internal Review and QC in Regulatory Writing
High-quality regulatory submissions are critical for successful approvals. Agencies like the FDA, the EMA, and the CDSCO require submissions that are scientifically sound, consistent, and compliant. To achieve this, regulatory writers rely on internal review and quality check (QC) processes. These processes ensure that dossiers — whether INDs, NDAs, BLAs, MAAs, or DMFs — are error-free, consistent across modules, and inspection-ready. By 2025, QC processes have evolved to integrate AI-driven tools, harmonized checklists, and cross-functional review frameworks that reduce errors and accelerate submissions.
For RA professionals, building robust review and QC systems is no longer optional but a regulatory necessity for global compliance.
Key Concepts in Review and Quality Checks
Internal review and QC processes focus on several key principles:
- Accuracy: Ensure data integrity and alignment with source documents.
- Consistency: Verify alignment across CTD modules (nonclinical, clinical, and CMC).
- Compliance: Check adherence to ICH M4, FDA, EMA, and CDSCO submission requirements.
- Traceability: Confirm that every data point is verifiable and linked to source documentation.
- Inspection Readiness: Prepare dossiers to withstand regulatory scrutiny without
Together, these concepts ensure regulatory documents are reviewer-friendly, audit-proof, and globally compliant.
Regulatory Frameworks and Global Expectations
Agencies emphasize internal QC as part of submission compliance:
- FDA: Expects responses, CRL replies, and dossier modules to be factually accurate and consistent across submissions.
- EMA: Assesses dossier consistency during Day 120/180 reviews; CHMP and PRAC demand harmonized safety, efficacy, and quality data.
- CDSCO: Requires CTD/eCTD submissions reviewed for internal accuracy before submission; deficiencies often arise from poor QC.
These frameworks highlight that internal review is an implicit regulatory expectation, even though it is not always explicitly mandated.
Processes and Workflow for Internal Review
A structured review and QC workflow ensures reliable submissions:
- Draft Creation: Regulatory writers prepare CTD modules using harmonized templates.
- First-Level Review: Conduct peer review within the regulatory writing team for structural and content accuracy.
- Cross-Functional Review: Engage clinical, nonclinical, QA, and CMC teams for technical accuracy.
- QC Checklists: Apply agency-specific and ICH-based checklists to verify compliance.
- Formatting Review: Confirm eCTD formatting, hyperlinks, and metadata accuracy.
- Final Approval: Obtain sign-off from RA leadership or regulatory quality teams before submission.
This workflow balances efficiency with regulatory rigor, ensuring inspection-ready documents.
Case Study 1: FDA NDA Review Deficiencies
Case: An NDA submission was delayed after FDA identified inconsistencies between Modules 2.5 and 5.
- Challenge: Lack of cross-checking between efficacy summaries and full study reports.
- Action: Sponsor introduced a cross-functional review step and QC checklist integration.
- Outcome: Resubmission passed review with no further deficiencies.
- Lesson Learned: Cross-functional QC prevents data misalignment across CTD modules.
Case Study 2: EMA Day 180 Queries Avoided
Case: A European MAA submission was praised for its consistency between nonclinical and clinical summaries.
- Challenge: High data volume risked discrepancies between Modules 2.4, 2.6, and 4.
- Action: Regulatory team implemented layered QC checks across modules.
- Outcome: EMA raised no major queries during Day 180 review.
- Lesson Learned: Strong QC reduces regulator queries and accelerates approvals.
Tools, Templates, and Systems
QC processes depend on structured tools and systems:
- Checklists: FDA, EMA, and CDSCO checklists ensure compliance with regional requirements.
- Document Management Systems (EDMS): Maintain version control and audit trails.
- AI-Based Tools: Automate cross-checking of data across modules.
- QC Templates: Standardize reviews with predefined QC steps for each module.
- eCTD Validators: Detect formatting errors and ensure technical compliance before submission.
These tools improve efficiency and minimize deficiencies in regulatory dossiers.
Common Challenges and Best Practices
RA teams face several challenges in internal reviews:
- Resource Constraints: Limited time and reviewers can compromise QC depth.
- Data Inconsistencies: Misalignment between modules remains a top cause of deficiencies.
- Documentation Burden: Managing large volumes of data increases risk of oversight.
- Global Variations: Differing expectations across FDA, EMA, and CDSCO complicate reviews.
Best practices include adopting multi-layered QC, training teams on templates, using automated validation tools, and scheduling sufficient review time.
Latest Updates and Strategic Insights
By 2025, internal review and QC processes are shaped by new trends:
- AI-Driven QC: Automates consistency checks across CTD modules.
- Global Harmonization: ICH promoting unified QC frameworks for eCTD submissions.
- Transparency: Agencies expecting internal QC evidence during inspections.
- Digital Submissions: Increasing reliance on metadata-driven QC for eCTD readiness.
- Inspection Focus: Regulators scrutinizing QC processes as part of Good Submission Practices (GSubP).
Strategically, RA professionals must adopt digital tools, harmonize QC frameworks, and document internal review processes for inspection readiness.
Conclusion
Internal review and quality check processes are essential for regulatory writing, ensuring submissions are accurate, consistent, and globally compliant. By mastering FDA, EMA, and CDSCO expectations and adopting harmonized QC frameworks, RA professionals can deliver inspection-ready dossiers. In 2025 and beyond, AI-driven QC, global harmonization, and documented internal review systems will define best practices in regulatory submissions.